embecta to Participate at the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Embecta Corp. (NASDAQ: EMBC) has announced its participation in the upcoming J.P. Morgan Healthcare Conference on January 11, 2023, at 9:45 a.m. PT / 12:45 p.m. ET. The company, known for its significant role in diabetes care, previously operated under Becton, Dickinson and Company. Interested parties can access audio webcasts of the presentation through the Company’s investor relations website. With nearly 100 years in insulin delivery, Embecta aims to enhance the lives of individuals with diabetes through innovative solutions and a dedicated workforce of over 2,000 employees worldwide.

PARSIPPANY, N.J., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 11, 2023 at 9:45 a.m. PT / 12:45 p.m. ET.

Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at investors.embecta.com.

About embecta 
embecta, formerly part of BD (Becton, Dickinson and Company), is one of the largest pure-play diabetes care companies in the world, leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visit embecta.com.

CONTACTS 
 
Investors:
Pravesh Khandelwal
VP, Head of Investor Relations
551-264-6547 
Contact IR

Media:
Christian Glazar
Sr. Director, Corporate Communications 
908-821-6922 
Contact Media Relations 

FAQ

When will Embecta Corp. present at the J.P. Morgan Healthcare Conference?

Embecta Corp. will present at the J.P. Morgan Healthcare Conference on January 11, 2023, at 9:45 a.m. PT / 12:45 p.m. ET.

How can I access the audio webcasts of Embecta's presentation?

Audio webcasts of Embecta's presentation can be accessed through the 'News & Events' section on the Company's investor relations website.

What is Embecta Corp.'s focus in the diabetes care market?

Embecta Corp. focuses on diabetes care, leveraging nearly 100 years of experience in insulin delivery to empower individuals with diabetes.

What is the stock symbol for Embecta Corp.?

The stock symbol for Embecta Corp. is EMBC.

What significant change did Embecta Corp. undergo recently?

Embecta Corp. was formerly part of BD (Becton, Dickinson and Company) and has transitioned to being a standalone diabetes care company.